UPDATE 1-Solid Biosciences medicines chief to step down, to cut workforce by one third

Solid Biosciences Inc said on Thursday its head of medicines would step down and that it would layoff one third of its workforce as the drug developer works to bring an end to the clinical halt on a trial of its experimental gene therapy.